2 completed, 1 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
Follow Lars Vedel Kessing: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Melatonin Versus Placebo for Bipolar Disorder Melatonin, Placebo - Bipolar Affective Disorder | Phase 2 | Recruiting | Lars Vedel Kessing | 200 | 2026-05-08 | 2026-05-12 |
| Effects of Low Dose Aspirin in Bipolar Disorder (The A-Bipolar RCT) acetylsalicylic acid, Calcium - Bipolar Disorder | Phase 2 | Completed | Lars Vedel Kessing | 250 | 2022-01-20 | 2025-01-29 |
| Effects of Erythropoietin on Cognition and Neural Activity in Mood Disorders Erythropoietin, Saline - Bipolar Disorder, Cognitive Impairment | Phase 2 | Completed | Lars Vedel Kessing | 103 | 2017-07-05 | 2023-03-16 |
Bipolar Disorder (3) · Bipolar and Related Disorders (1) · Cognitive Dysfunction (1) · Depressive Disorder (1) · Mental Disorders (1) · Mood Disorders (1)
Aspirin (1) · Calcium (1) · Epoetin Alfa (1) · Erythropoietin (1) · Melatonin (1) · Sodium Chloride (1)
Denmark (3)
Kamilla W. Miskowiak, Prof. (1) · Lars Kessing (1) · Lars V. Kessing, Prof. (1)
PMID 30400939, PMID 38519416, PMID 39557557, PMID 41319159
2016 (1)